Steven Cummings, MD: The denosumab FREEDOM trial
Dr. Steven Cummings, director of the San Francisco Coordinating Center and faculty of UCSF, and principle investigator of the Amgen FREEDOM trial, discusses the results of the trial. FREEDOM looked at...
View ArticleDavid Wofsy, MD: Guidelines for industry funding of medical societies
Dr. Wofsy discusses the recent article in JAMA, which he co-authored, on the handling of industry payments to medical societies. A similar paper a few years ago caused significant changes in the way...
View ArticleStacy Ardoin, MD, Carlos Lozada, MD: Benlysta (belimumab) for lupus
Lupus has been a challenging disease with little clinical progress for decades. This may change soon if a new drug branded as Benlysta (belimumab) is approved. The series of BLISS trials met the...
View ArticleFDA CDER Director on Benlysta for lupus and adaptive clinical trials.
(In 108iHD) Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer, MD the first drug approved to treat lupus in 50 years, Benlysta (belimumab). The BLISS trials...
View ArticleCeliac disease is not reduced by breast feeding or delaying the introduction...
October 19, 2014- Interviewed by Steven E. Greer, MD Alessio Fasano, MD of Harvard discusses his 10-year-long study in children testing whether the delayed introduction of gluten into the diet reduced...
View Article
